BioCentury
ARTICLE | Financial News

Valentis raises $19.2 million

April 14, 2000 7:00 AM UTC

Gene therapy company VLTS sold 1.915 million shares at $10.00 per share in a private placement. Investors included the State of Wisconsin Investment Board; BayStar Capital; Merlin BioMed Asset Managem...